Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
36949 Cook St
Ste 101
Palm Desert, CA 92211Phone+1 760-340-2394Fax+1 760-340-2369- Is this information wrong?
Education & Training
Charles Retina InstitutePost-fellowship elective, 1995 - 1996
Washington University/B-JH/SLCH ConsortiumFellowship, Surgical Retina and Vitreous, 1994 - 1995
Loma Linda University Health Education ConsortiumResidency, Ophthalmology, 1981 - 1984
Adventist Health White MemorialInternship, Transitional Year, 1980 - 1981
Loma Linda University School of MedicineClass of 1980- Pacific Union CollegeB.S., Biochemistry, Magna Cum Laude, 1973 - 1977
Certifications & Licensure
CA State Medical License 1981 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Clinical Professor, Clinician Scientist School of Medicine, Loma Linda University, Loma Linda, California, 2016
- Regional Top Doctor Castle Connolly, 2014
- Nomination American Ophthalmological Society (AOS), 2013
- Join now to see all
Clinical Trials
- Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments Start of enrollment: 2008 Sep 01
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- Decoding Scleral Structures With Polarized Light.Clement K Chan, Martha Henao> ;JAMA Ophthalmology. 2024 Mar 7
- Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Humayun, M., Clegg, D., Dayan, M., Kashani, A., Rahhal, F., Avery, R., Salehi-Had, H., Chen, S., Chan, C., Palejwala, N., Ingram, A., Mitra, D., Pennington, B., Hinman...> ;Ophthalmology. 2023 Dec 30
- Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration.Clement K Chan, Wesley T Beaulieu, Brandon J Lujan, Maziar Lalezary, Daniella Lent-Schochet, Therlinder Lo, Glenn Yiu> ;Translational Vision Science & Technology. 2023 Sep 1
- Join now to see all
Journal Articles
- Prospective Evaluation of the Incidence and Risk Factors for the Development of RPE Tears after High-and Low-dose Ranibizumab TherapySarraf D, Chan CK, Rahimy E, Abraham P, Retina, 1/1/2013
- Exploratory Analysis of Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical TrialBressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Stone T, for the Diabetic Retinopathy Clinical Research Network, JAMA Ophthalmol, 1/1/2013
- Response to the Letter by Talks Et Al (June 27, 2012) On High-dose Ranibizumab Therapy for Vascularized Pigment Epithelial DetachmentChan CK, Sarraf D, EYE: Advance Online Publication, 10/19/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular DegenerationChan CK, Jain A, Sadda S, Varshney N, Session 383, CNV Management, ARVO Annual Meeting: Leading Eye and Vision Research, Orlando Convention Center, Orlando, FL, 5/6/2014
- The EVEN Study: An In-depth Prospective Trial on Intravitreal Aflibercept Treatment of Submacular Vascularized Pigment Epithelial DetachmentLalezary M, Sarraf D, Abraham P, Lin SG, Chan CK, Session 383, CNV Management, ARVO Annual Meeting: Leading Eye and Vision Research, Orlando Convention Center, Orlando, FL, 5/6/2014
- Pneumatic Maculopexy: A Novel Approach for Treatment of Symptomatic Vitreomacular TractionMein C, Chan CK, Session 110, Vitreomacular Interface and Management, ARVO Annual Meeting: Leading Eye and Vision Research, Orlando Convention Center, Orlando, FL, 5/4/2014
- Join now to see all
Lectures
- Comparison of Visual and OCT Outcomes in Eyes with and without Prior Vitrectomy Receiving Anti-VEGF Therapy in a Randomized Trial on Ranibizumab Prompt or Deferred Las...Kongresshaus, Zurich, Switzerland - 9/5/2014
- Pharmacodynamic and Pharmacokinetic Profile of Intraocular Aflibercept (Eylea) in Patients with Neovascular AMD Receiving Intravitreal Aflibercept TherapyKongresshaus, Zurich, Switzerland - 9/4/2014
- Gas Injection for Vitreomacular Traction in the Era of Pharmacologic Vitreolysis, a Case ReportKongresshaus, Zurich, Switzerland - 9/3/2014
- Join now to see all
Press Mentions
Biologists Design a Plug-and-Play Controller for Gene ExpressionJuly 11th, 2019
Professional Memberships
- Fellow
- Member
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
